Hussein Maha, Saif Aasem, Amin Mona, Khalafallah Osama, Hussien Ahmed, Aboulsoud Samar, Mousa Shrook
Internal Medicine Department, Cairo University, Giza, Egypt.
Clinical and Chemical Pathology Department, Cairo University, Giza, Egypt.
J Nutr Metab. 2023 Aug 31;2023:6661585. doi: 10.1155/2023/6661585. eCollection 2023.
The study included 200 Egyptian subjects. They were divided into four equal groups: group 1: obese patients with NAFLD and T2DM (O+/NAFLD+/DM+), group 2: nonobese patients with NAFLD and T2DM (O-/NAFLD+/DM+), group 3: obese nondiabetic patients with NAFLD (O+/NAFLD+/DM-), and group 4: nonobese healthy control subjects. Plasma adiponectin was measured using ELISA (enzyme-linked immunosorbent assay) technique. Ultrasonography was used to diagnose NAFLD. CIMT was assessed using Doppler ultrasonography. Plasma adiponectin was significantly lower and CIMT was significantly higher in O+/NAFLD+/DM+, as compared with O-/NAFLD+/DM+, O+/NAFLD+/DM-, and control subjects ( < 0.001 for all). A significant negative correlation was found between adiponectin and CIMT in obese patients with NAFLD ( < 0.05), but not in patients with NAFLD and T2DM. The significant independent predictors of CIMT were diabetes duration, BMI (body mass index), albumin/creatinine ratio, and cholesterol.
Plasma adiponectin is inversely correlated with CIMT in obese patients with NAFLD, but not in patients with NAFLD and T2DM. Hypoadiponectinemia could be a good indicator of cardiovascular risk in obese patients with NAFLD, with or without T2DM, but not in nonobese patients with NAFLD.
该研究纳入了200名埃及受试者。他们被分为四组,每组人数相等:第1组:患有非酒精性脂肪性肝病(NAFLD)和2型糖尿病(T2DM)的肥胖患者(O+/NAFLD+/DM+);第2组:患有NAFLD和T2DM的非肥胖患者(O-/NAFLD+/DM+);第3组:患有NAFLD的肥胖非糖尿病患者(O+/NAFLD+/DM-);第4组:非肥胖健康对照受试者。采用酶联免疫吸附测定(ELISA)技术检测血浆脂联素。使用超声检查诊断NAFLD。采用多普勒超声评估颈动脉内膜中层厚度(CIMT)。与O-/NAFLD+/DM+组、O+/NAFLD+/DM-组和对照组相比,O+/NAFLD+/DM+组的血浆脂联素显著降低,CIMT显著升高(所有比较P<0.001)。在患有NAFLD的肥胖患者中,脂联素与CIMT之间存在显著负相关(P<0.05),但在患有NAFLD和T2DM的患者中未发现这种相关性。CIMT的显著独立预测因素为糖尿病病程、体重指数(BMI)、白蛋白/肌酐比值和胆固醇。
在患有NAFLD的肥胖患者中,血浆脂联素与CIMT呈负相关,但在患有NAFLD和T2DM的患者中并非如此。低脂联素血症可能是患有或未患有T2DM的NAFLD肥胖患者心血管风险的良好指标,但在患有NAFLD的非肥胖患者中并非如此。